ZA986138B - Combinations of selective serotonin re-update inhibitors and B-blockers. - Google Patents
Combinations of selective serotonin re-update inhibitors and B-blockers.Info
- Publication number
- ZA986138B ZA986138B ZA9806138A ZA986138A ZA986138B ZA 986138 B ZA986138 B ZA 986138B ZA 9806138 A ZA9806138 A ZA 9806138A ZA 986138 A ZA986138 A ZA 986138A ZA 986138 B ZA986138 B ZA 986138B
- Authority
- ZA
- South Africa
- Prior art keywords
- blockers
- inhibitors
- update
- combinations
- selective serotonin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA986138B true ZA986138B (en) | 2000-01-10 |
Family
ID=10815744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9806138A ZA986138B (en) | 1997-07-11 | 1998-07-10 | Combinations of selective serotonin re-update inhibitors and B-blockers. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0996466A2 (es) |
| JP (1) | JP2002508003A (es) |
| KR (1) | KR20010021644A (es) |
| CN (1) | CN1262627A (es) |
| AP (1) | AP2000001728A0 (es) |
| AR (1) | AR016128A1 (es) |
| AU (1) | AU9340198A (es) |
| BG (1) | BG104119A (es) |
| BR (1) | BR9810996A (es) |
| CA (1) | CA2295822A1 (es) |
| CO (1) | CO4950552A1 (es) |
| DZ (1) | DZ2556A1 (es) |
| EA (1) | EA200000112A1 (es) |
| GB (1) | GB9714675D0 (es) |
| HU (1) | HUP0003074A3 (es) |
| ID (1) | ID24191A (es) |
| IL (1) | IL133869A0 (es) |
| MA (1) | MA24604A1 (es) |
| NO (1) | NO20000107L (es) |
| OA (1) | OA11276A (es) |
| PE (1) | PE99699A1 (es) |
| PL (1) | PL338017A1 (es) |
| SK (1) | SK72000A3 (es) |
| TR (1) | TR200000074T2 (es) |
| WO (1) | WO1999002142A2 (es) |
| ZA (1) | ZA986138B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7417038B1 (en) | 1998-10-15 | 2008-08-26 | Imperial Innovations Limited | Methods of treating cachexia |
| PL205109B1 (pl) | 1998-11-02 | 2010-03-31 | Elan Pharma Int Ltd | Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie |
| ATE526950T1 (de) | 1999-10-29 | 2011-10-15 | Euro Celtique Sa | Hydrocodon-formulierungen mit gesteuerter freisetzung |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
| EP2263658A1 (en) | 2000-10-30 | 2010-12-22 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
| EP1793818A2 (en) * | 2004-09-17 | 2007-06-13 | Neurocure Ltd. | Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| CN100469356C (zh) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | 复方阿替洛尔缓释片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732335C2 (de) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten |
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
| ES2145977T3 (es) * | 1995-08-16 | 2000-07-16 | Lilly Co Eli | Potenciacion de la respuesta de la serotonina. |
| EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Application Discontinuation
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/xx active
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107L/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1262627A (zh) | 2000-08-09 |
| BG104119A (en) | 2000-12-29 |
| HUP0003074A2 (hu) | 2001-01-29 |
| WO1999002142A2 (en) | 1999-01-21 |
| KR20010021644A (ko) | 2001-03-15 |
| NO20000107D0 (no) | 2000-01-10 |
| AP2000001728A0 (en) | 2000-03-31 |
| AU9340198A (en) | 1999-02-08 |
| WO1999002142A3 (en) | 1999-04-15 |
| PE99699A1 (es) | 1999-12-21 |
| HUP0003074A3 (en) | 2001-12-28 |
| OA11276A (en) | 2003-07-31 |
| JP2002508003A (ja) | 2002-03-12 |
| NO20000107L (no) | 2000-01-10 |
| PL338017A1 (en) | 2000-09-25 |
| EP0996466A2 (en) | 2000-05-03 |
| EA200000112A1 (ru) | 2000-10-30 |
| CA2295822A1 (en) | 1999-01-21 |
| SK72000A3 (en) | 2000-12-11 |
| CO4950552A1 (es) | 2000-09-01 |
| ID24191A (id) | 2000-07-13 |
| GB9714675D0 (en) | 1997-09-17 |
| MA24604A1 (fr) | 1999-04-01 |
| AR016128A1 (es) | 2001-06-20 |
| IL133869A0 (en) | 2001-04-30 |
| TR200000074T2 (tr) | 2000-05-22 |
| DZ2556A1 (fr) | 2003-02-15 |
| BR9810996A (pt) | 2000-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA973146B (en) | Prodrugs of COX-2 inhibitors. | |
| IL121076A (en) | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors | |
| ID23983A (id) | Inhibitor-inhibitor aminotiazol untuk kinase-kinase tergantung siklin | |
| HK1049630A1 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same. | |
| ZA973397B (en) | Inhibitors of IMPDH enzyme. | |
| ZA991975B (en) | Enzyme inhibitors. | |
| ZA985778B (en) | Inhibitors of farnesyl protein transferase. | |
| NO20001651L (no) | Nedlasting av data | |
| BR0001422B1 (pt) | aparelho e mÉtodo de reproduÇço. | |
| DE69820138D1 (de) | Methode pour stimuler des formations souterraines non consolidees | |
| ZA200109994B (en) | Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors. | |
| DK1027332T3 (da) | Hidtil ukendte lactametalloproteaseinhibitorer | |
| PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
| NO20012691D0 (no) | Isomerisering av hydrokarboner | |
| HUP0101640A3 (en) | Certain thoil inhibitors of endothelin-converting enzyme | |
| NO996090D0 (no) | Forbedret foskefor og fremgangsmåte for anvendelse av dette | |
| AU4231699A (en) | Inhibitors of serotonin reuptake | |
| ZA986138B (en) | Combinations of selective serotonin re-update inhibitors and B-blockers. | |
| ZA977868B (en) | Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors. | |
| TR199501644A2 (tr) | Skualen sintetaz inhibitörleri. | |
| GB9816358D0 (en) | Enzyme inhibitors | |
| ITBO970057A0 (it) | Metodo di controllo di sigarette. | |
| NO20001569D0 (no) | Bisetere av 1-oksa, aza og tianaftalen-2-oner som fosfolambaninhibitorer | |
| ZA200110325B (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same. | |
| ZA988687B (en) | Selective cPLA2 inhibitors. |